0001209191-20-036308.txt : 20200612
0001209191-20-036308.hdr.sgml : 20200612
20200612164204
ACCESSION NUMBER: 0001209191-20-036308
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200612
DATE AS OF CHANGE: 20200612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwalm Cynthia
CENTRAL INDEX KEY: 0001741455
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 20960723
MAIL ADDRESS:
STREET 1: C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR.
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 PARK OFFICES DRIVE
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: 700 PARK OFFICES DRIVE
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-11
0
0001560241
G1 Therapeutics, Inc.
GTHX
0001741455
Schwalm Cynthia
C/O G1 THERAPEUTICS, 700 PARK OFFICES DR
SUITE 200
RESEARCH TRIANGLE PARK
NC
27709
1
0
0
0
Stock Option (right to buy)
17.59
2020-06-11
4
A
0
20000
0.00
A
2030-06-11
Common Stock
20000
20000
D
The shares underlying this option will vest in their entirety twelve months after June 11, 2020, subject to the Reporting Person's continued service as a director.
/s/ James Stillman Hanson, attorney in fact
2020-06-12